It was a busy week for the public relations staff at Novartis, the Swiss based pharmaceutical giant. Their Canadian subsidiary, Sandoz Canada, entered into a partnership with Tilray to develop cannabinoid medicines. And their Washington, DC lobbyists were exposed —by Stormy Daniels’ lawyer!— for having paid a $1.2 million fee to Michael Cohen, Donald Trump’s “fixer,” as a consultant on healthcare policy. Aren’t you glad they made cannabis safe for capitalism? —O’S News Service
About The Author
managing editor, O'Shaughnessy's.
July 28, 2015
June 21, 2018
February 23, 2018